PUERTO RICO INAUGURATES FIRST GENERICS DEVELOPMENT CENTRE

PUERTO Rico opened on January 31 its first centre for the research and development of generic pharmaceuticals - the Center for the Development and Innovation of Pharmaceutical Products. It will be operated by Mexico-based Neolpharma, according to Governor Alejandro Garcia Padilla's office. Neolpharma's "strategic move" to Puerto Rico means it can develop pharmaceuticals under US Food and Drug Administration's (FDA) regulations for the American market, said Antonio Medina, the executive director of the Puerto Rico Industrial Development Company - a ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.